Back to Search Start Over

Development of Enzymatic Depletion Methods for Preparation of Small Extracellular Vesicles with Long Blood-Circulation Half-Life.

Authors :
Kobayashi, Yuki
Kitamura, Shimpei
Takahashi, Yuki
Takakura, Yoshinobu
Source :
Pharmaceutical Research; Apr2023, Vol. 40 Issue 4, p855-861, 7p
Publication Year :
2023

Abstract

Purpose: Phosphatidylserine (PS)-deficient small extracellular vesicle (sEV) subpopulations (PS<superscript>(−)</superscript> sEVs) circulate in blood for long periods; hence, they are expected to have therapeutic applications. However, limited production of PS<superscript>(−)</superscript> sEVs makes their application difficult. In this study, a method for the preparation of such populations using an enzymatic reaction was developed. Methods: Bulk sEVs collected from a cell culture supernatant via ultracentrifugation were subjected to an enzymatic reaction using phosphatidylserine decarboxylase (PSD). The yield of PS<superscript>(−)</superscript> sEVs was estimated using magnetic beads that bind to PS<superscript>(+)</superscript> sEVs. Then, the physical properties and pharmacokinetics (PK) of the sEVs were evaluated. Results: Enzymatic depletion of PS exposed on sEV surfaces using PSD increased the yield of PS<superscript>(−)</superscript> sEVs. PSD treatment hardly changed the physicochemical properties of PS<superscript>(−)</superscript> sEVs. Moreover, the serum concentration profile and PK parameters of the PS<superscript>(−)</superscript> sEVs derived from PSD-treated bulk sEVs indicated a long blood-circulation half-life. Conclusions: Treatment of sEVs with PSD successfully reduced surface PS levels and increased the amount of the PS<superscript>(−)</superscript> sEV subpopulation among bulk sEVs. This protocol of efficient preparation of PS<superscript>(−)</superscript> sEVs based on PSD treatment, as well as information on the basic PK, can be foundational for the therapeutic application of sEVs. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
07248741
Volume :
40
Issue :
4
Database :
Complementary Index
Journal :
Pharmaceutical Research
Publication Type :
Academic Journal
Accession number :
163721909
Full Text :
https://doi.org/10.1007/s11095-022-03405-9